Investment Rating - The investment rating for the company is "Outperform the Market" [6][4]. Core Viewpoints - The company achieved rapid revenue growth in the first half of 2025, with revenue reaching 917 million RMB, a year-on-year increase of 189%, and adjusted net profit of 152 million RMB, up 179% [1][9]. - The company's comprehensive literacy business saw significant growth, with revenue of 723 million RMB, a staggering increase of 513% [10]. - The company is actively implementing its "ALL IN AI" strategy, enhancing its educational offerings and operational efficiency through AI technology [21][3]. - The company declared an interim dividend of 10.7 cents per share, with a payout ratio of approximately 60%, indicating a commitment to shareholder returns [23][3]. Financial Performance - The gross profit margin for the first half of 2025 was 45.0%, remaining stable year-on-year, while the net profit margin slightly decreased to 16.5% due to increased operating expenses [2][16]. - Contract liabilities increased by 28% year-on-year, indicating strong future revenue potential, with total liabilities reaching 587 million RMB [20]. - The company expects continued growth in net profit, projecting 339 million RMB for 2025, with a year-on-year growth rate of 76% [24][5]. Business Segmentation - The tutoring projects generated revenue of 89 million RMB, an 18% increase, while full-time review projects saw a decline of 18% in revenue to 101 million RMB due to increased competition and changes in demand [10][1]. - The company has expanded its workforce from 3,072 to 3,592 employees, supporting its growth strategy [20][2]. Valuation Metrics - The projected earnings per share (EPS) for 2025 is 0.40 RMB, with a price-to-earnings (PE) ratio of 12x, indicating a favorable valuation compared to peers [5][25]. - The company is expected to maintain a strong return on equity (ROE) of 43% in 2025, reflecting its efficient use of equity capital [5][26].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 79.25 HKD [5]. Core Insights - The company reported a revenue of 19.652 billion RMB for the first half of 2025, representing a year-over-year increase of 3.56%. Net profit reached 1.646 billion RMB, up 52.56% year-over-year, with a gross margin of 19.8% and a net margin of 8.8% [1]. - The company continues to lead the global market in mobile-related products, benefiting from the high-endization of smartphone cameras and its advanced technology, maintaining the highest market share [1]. - The automotive lens market is experiencing rapid growth, with the company also holding the top global market share in automotive lenses and expanding its product offerings through strategic partnerships with major players in the smart driving platform sector [1][2]. - The XR-related products are positioned to capitalize on the fast-growing AI/AR glasses market, with the company maintaining a leading market position in imaging modules for smart glasses [2]. - The company is expanding its presence in the IoT market, with increasing demand for optical components and optoelectronic products driven by the rise of handheld photography devices and machine vision applications [2]. Financial Forecasts - Revenue projections for 2025, 2026, and 2027 are 43.724 billion RMB, 48.699 billion RMB, and 53.279 billion RMB, respectively, with corresponding net profits of 3.712 billion RMB, 4.528 billion RMB, and 5.137 billion RMB [4]. - The company is expected to achieve a PE ratio of 22, 18, and 16 for the years 2025, 2026, and 2027, respectively [4].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 62.3 HKD, representing an upside potential of 18.6% from the recent closing price of 52.55 HKD [7]. Core Insights - The company achieved record-high revenue and adjusted net profit in Q2 2025, with revenue reaching 1159.6 billion RMB, a year-on-year increase of 30.5%, and adjusted net profit of 108.3 billion RMB, up 75.4% year-on-year, slightly exceeding Bloomberg consensus expectations [1]. - The growth is driven by three main factors: the high-end smartphone strategy and market share increase, the expanding scale effects of the AIoT ecosystem, and the strong performance of the smart electric vehicle business [1][4]. Summary by Sections Smartphone Performance - In Q2 2025, the company's smartphone revenue decreased by 2.1% to 455.2 billion RMB, primarily due to a 2.7% decline in average selling price (ASP) to 1073.2 RMB, partially offset by a 0.6% increase in shipment volume to 42.4 million units [2]. - Despite a 3.8% decline in smartphone shipments in mainland China, the company managed a 3.6% increase in its own shipments, outperforming peers [2]. IoT and Internet Services - Revenue from IoT and lifestyle products reached 387.1 billion RMB in Q2, marking a 44.7% year-on-year growth, with a gross margin of 22.5%, up 2.8 percentage points [3]. - Internet services revenue grew by 10.1% year-on-year to 91.0 billion RMB, maintaining a gross margin of 75.4% [3]. Automotive Business - The company delivered 81,302 vehicles in Q2, setting a new record, with the first SUV model, Xiaomi YU7, achieving over 240,000 orders within 18 hours of launch [3]. - The ASP for the new model reached 253,700 RMB, a 10.9% increase year-on-year, indicating a shift towards higher-end products and improved profitability [3]. Financial Projections - The company is projected to achieve total revenue of 483.4 billion RMB in FY 2025, with a year-on-year growth of 32.1% [5]. - Adjusted net profit is expected to reach 42.5 billion RMB in FY 2025, reflecting a significant year-on-year increase of 56.0% [5].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected investment return that will outperform the market benchmark by over 20% in the next 6-12 months [6][11]. Core Insights - The company achieved a revenue of $519 million in the first half of 2025, representing an increase of 81.9%. The gross profit was approximately $320 million, up 140.1%, and the adjusted net profit was about $178 million, reflecting a significant increase of 509.6%. The net loss was reduced to $24.5 million compared to a net loss of $216 million in the same period of 2024 [1][6]. Summary by Sections Financial Performance - In H1 2025, the life sciences services and products generated approximately $248 million in revenue, a growth of 11.3%, with an adjusted gross profit of $126 million, up 5.3%. The adjusted operating profit was about $46.35 million, down 3.2% [2]. - The CDMO segment reported revenue of approximately $247 million, a remarkable increase of 511.1%, with an adjusted operating profit of $150 million, compared to a loss of $18.88 million in H1 2024. This growth was driven by significant licensing revenue and double-digit growth in regular income [2]. - The company secured 20 new CDMO projects for antibody protein drugs, with over 50% from global clients, and 30 new CDMO projects in CGT, including one CAR-T project [2]. Revenue and Profit Forecast - The company forecasts revenues of $927 million, $803 million, and $905 million for 2025, 2026, and 2027, respectively, with growth rates of 56.0%, -13.4%, and 12.6% [3][4]. - The adjusted net profit is expected to be $84 million in 2025, with a significant recovery projected in subsequent years [4]. Key Financial Metrics - The company reported a gross margin of 48.8% in 2023, expected to rise to 56.8% in 2025, and a projected return on equity (ROE) of 1.9% in 2025, improving to 6.4% by 2027 [10]. - The earnings per share (EPS) is projected to be $0.04 in 2025, with a price-to-earnings (P/E) ratio of 472.05 [4][10].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [6]. Core Insights - The company reported a revenue of 60.13 billion yuan for the first half of 2025, representing an 18.3% year-on-year growth. Gross profit reached 22.44 billion yuan, up 16.6%, with a gross margin of 37.3%, slightly down by 0.5 percentage points. However, net profit decreased by 28.0% to 4.92 billion yuan, and adjusted net profit was 7.37 billion yuan, down 2.1% [1][5]. - The company's self-owned brand business, primarily from electronic vapor products and vapor beauty products, generated 12.74 billion yuan in revenue, a 14.1% increase, accounting for 21.2% of total revenue. The European market contributed 10.69 billion yuan, up 15.1%, while the U.S. market saw a decline of 6.7% to 1.74 billion yuan. Notably, the Chinese market surged by 2595.2% to 306.18 million yuan, driven by the sales of the vapor beauty product "Lan Zhi" [2][3]. - The company is experiencing a recovery in its vapor electronic cigarette business, supported by stricter regulations against non-compliant products in global markets. This regulatory environment is expected to sustain growth in both self-owned brand and enterprise client businesses [3][4]. Segment Summaries - **HNB Products**: The company successfully supported strategic clients in launching the high-end HNB product Hilo series, which will be launched nationwide in Japan in September 2025. The company is committed to ongoing R&D in HNB products to address user pain points [4]. - **Vapor Medical**: The subsidiary, Chuan Si Bio, is focused on developing leading generic drugs for asthma and COPD in the U.S. and Europe, with plans for further collaboration with international pharmaceutical companies [4]. - **Vapor Beauty**: The "Lan Zhi" home beauty device has surpassed 10,000 users, and the professional equipment has received Class II medical device certification, with over 100 private institutions procuring it [4]. Profit Forecast and Investment Recommendations - The company is positioned as a global leader in vapor technology solutions, with increasing competitive advantages. The report anticipates significant contributions from HNB business starting in 2026, with adjusted net profit forecasts for 2025-2027 set at 14.72 billion, 19.79 billion, and 26.63 billion yuan, respectively, reflecting year-on-year growth rates of 34.40% and 34.60% for 2026 and 2027 [5].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][5] Core Insights - The company has demonstrated significant growth in revenue and profit in the first half of 2025, with revenue reaching 13.88 billion (up 204.4% year-on-year) and net profit of 4.57 billion (up 396.5%) [5] - The company expects full-year revenue for 2025 to be no less than 30 billion, with plans to increase its overseas store count to 200 and domestic store count by approximately 10 [5] - The report highlights the company's strong performance in both domestic and international markets, with a notable increase in the contribution from overseas operations [6][7] Financial Performance - In H1 2025, the company achieved a gross margin of 70.3% (up 6.3%), driven by a higher proportion of overseas business and improved supply chain efficiency [6] - The net profit margin reached 33.0% (up 12.8 percentage points), indicating significant improvement in profitability [6] - The company has 13 IPs generating over 100 million in revenue, with five IPs exceeding 1 billion, showcasing the effectiveness of its diversified IP strategy [6] Revenue Breakdown - Domestic revenue (including mainland China and Hong Kong, Macau, and Taiwan) was 82.8 billion (up 135%), with retail store revenue at 44.1 billion (up 120%) [7] - Overseas revenue reached 55.9 billion (up 440%), accounting for 40.3% of total revenue, with significant growth in the Americas [7] - The company plans to expand into South America and the Middle East in 2025, anticipating further revenue growth in these regions [7] Valuation Metrics - The projected net profit for 2025-2027 is estimated at 10.79 billion, 15.03 billion, and 20.21 billion respectively, with corresponding EPS of 8.0, 11.2, and 15.1 [5][9] - The current P/E ratios for 2025, 2026, and 2027 are 32.2, 23.1, and 17.2 respectively, indicating a favorable valuation outlook [5][9]

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Views - The company achieved a revenue of 138.8 billion RMB in 1H25, representing a year-on-year increase of 204.4%, with a gross profit of 97.6 billion RMB and a gross margin of 70.3%, up 6.3 percentage points year-on-year [1] - The company expects to generate at least 300 billion RMB in revenue for the year 2025, with an adjusted net profit margin projected at around 35% [1] Revenue Breakdown - In 1H25, revenue from China was 82.8 billion RMB, a year-on-year increase of 135.2%, accounting for 59.7% of total revenue [2] - The Asia-Pacific region generated 28.5 billion RMB, up 257.8% year-on-year [2] - The Americas saw revenue of 22.7 billion RMB, a staggering increase of 1142.3% year-on-year [2] - Europe and other regions contributed 4.8 billion RMB, reflecting a year-on-year growth of 729.2% [2] IP and Product Categories - In 1H25, five IPs generated over 1 billion RMB in revenue, with THE MONSTERS accounting for 34.7% of total revenue [3] - Plush toys have become the largest product category, increasing from less than 10% in 24H1 to 44% [3] - The company has improved operational efficiency, with a gross margin increase attributed to higher overseas pricing and reduced promotional activities [3] Financial Forecasts - The adjusted net profit forecasts for 2025-2027 have been raised to 111 billion RMB, 170 billion RMB, and 212 billion RMB, respectively, reflecting increases of 70%, 77%, and 72% from previous estimates [4] - Revenue projections for 2025 are set at 32.5 billion RMB, with a growth rate of 149% [5] Valuation Metrics - The adjusted P/E ratio is projected to decrease from 329 in 2023 to 18 by 2027, indicating a significant improvement in valuation as earnings grow [5]

Investment Rating - The report maintains a "Buy" rating for AIA Group Limited (1299.HK) with a current price of HKD 73.45 [1] Core Insights - AIA Group achieved a post-tax operating profit of USD 3.61 billion in the first half of 2025, representing a year-on-year increase of 7% (fixed exchange rate) and 6.6% (actual exchange rate) [4][12] - The new business value reached USD 2.84 billion, up 14% (fixed exchange rate) and 15.6% (actual exchange rate) year-on-year, driven by increased sales and improved profitability of new business [5][12] - The embedded value stood at USD 70.85 billion, reflecting a 2.6% increase from the beginning of the year [4] Summary by Sections New Business Value - The new business value for the first half of 2025 was USD 2.84 billion, with quarterly growth rates of 12.8% and 18.9% for Q1 and Q2 respectively, primarily due to increased sales and enhanced profitability [5][6] - Annualized new premiums amounted to USD 4.94 billion, showing an 8.7% increase year-on-year [5] - The new business value margin recorded 57.7%, up 3.8 percentage points year-on-year, benefiting from product structure optimization and repricing in the Thailand and mainland China markets [5][6] Market Contributions - In mainland China, the new business value was USD 740 million, down 5% year-on-year, but showed a 10% increase when excluding economic assumption changes [6][11] - The Hong Kong market contributed significantly, with new business value increasing by 23.9% to USD 1.06 billion, maintaining its position as the largest contributor to the group's new business value [7][11] - The Southeast Asian market, particularly Thailand, saw a 45.4% increase in new business value to USD 520 million, aided by regulatory changes and strategic partnerships [8][11] Financial Performance - The net profit attributable to shareholders was USD 2.53 billion, down 23.5% year-on-year, mainly due to increased financial expenses related to insurance contracts [12] - The company returned USD 3.71 billion to shareholders through dividends and share buybacks, with an interim dividend of HKD 0.49 per share, up 10.1% year-on-year [12] - The report projects a downward revision of net profit forecasts for 2025-2027 to USD 7.0 billion, USD 7.6 billion, and USD 8.3 billion respectively [13]

证券研究报告·海外公司点评·公用事业Ⅱ(HS) 昆仑能源（00135.HK） 2025 年中报点评：售气价差回落&补贴确认 减少导致业绩承压，DPS 提升 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 177,726 | 187,046 | 194,158 | 206,079 | 217,252 | | 同比(%) | 3.16 | 5.24 | 3.80 | 6.14 | 5.42 | | 归母净利润（百万元） | 5,682 | 5,960 | 6,061 | 6,341 | 6,635 | | 同比(%) | 8.68 | 4.89 | 1.70 | 4.61 | 4.63 | | EPS-最新摊薄（元/股） | 0.66 | 0.69 | 0.70 | 0.73 | 0.77 | | P/E（现价&最新摊薄） | 10.29 | 9.81 | 9.65 | 9.22 | 8.81 | [Table_Ta ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [3][18]. Core Insights - The company reported a total operating revenue of USD 1.24 billion for 1H25, representing a year-on-year increase of 6%. The net profit after tax was USD 342 million, which is a 20% increase compared to the core net profit from 1H24 [6][8]. - The company has significantly expanded its order book, with a projected 26% year-on-year increase in deliveries for 2025. The fleet size at the end of 1H25 was 834 aircraft, with a utilization rate of 100% for owned aircraft [8]. - The company is well-positioned to benefit from strong demand in the Asia-Pacific region, which is expected to contribute significantly to its revenue growth [8]. Financial Data and Earnings Forecast - The projected operating revenue for the company from 2023 to 2027 is as follows: - 2023: 2,461 million - 2024: 2,557 million - 2025E: 2,586 million - 2026E: 2,715 million - 2027E: 2,828 million - The net profit forecast for the same period is: - 2023: 764 million - 2024: 924 million - 2025E: 702 million - 2026E: 739 million - 2027E: 763 million - The earnings per share (EPS) is expected to be: - 2023: 1.10 - 2024: 1.33 - 2025E: 1.01 - 2026E: 1.06 - 2027E: 1.09 [7][9]. Operational Insights - The company has signed new aircraft purchase commitments for 143 aircraft, expanding its order book to 351 aircraft. The average age of the fleet is 5.0 years, significantly younger than the global average of 15 years [8]. - The net leasing yield increased to 7.5% in 1H25, up from 7.0% in 1H24, driven by the appreciation of aircraft assets [8]. - The company’s annualized funding cost remained stable at 4.6%, with the lowest spread in the industry for newly issued bonds [8].